Treatment of Diabetes (Part 4): Panel Discussion (ARCHIVES)

*Note: All information and materials provided has expired for CME credit possibilities and is solely to be used for informational purposes only.


The panel will deliberate about the benefits of using a low-carbohydrate or low-fat approach for diabetes treatment.

Disclosures (at time of recording):   Speakers:

  • John Foreyt, PhD: Nothing to disclose
  • Kevin C. Maki, PhD, CLS, FNLA, FTOS: Kellogg: Advisory Board and Research; National Dairy Council: Advisory Board and Research; American Egg Board: Advisory Board and Research; National Cattleman’s Beef Association: Advisory Board and Research; Biofortis: Advisory Board
  • William S. Yancy, Jr., MD, MHS: NutriSystem: Advisory Board; Weight Watchers: Research; ViiV Healthcare: Spouse Part-time Employment


  • Eric C. Westman, MD, MHS: Vivus: Speakers Bureau; Eisai: Speakers Bureau; KE Diet: Advisory Board; Invoy: Advisory Board; Low Carbohydrate Ketogenic Diet Manual: Royalties; Cholesterol Clarity: Royalties; Keto Clarity: Royalties; Low Carb Adapt Website: Co-founder
  • Nothing to Disclose: Richard David Feinman, PhD; Dana Mansell, CHCP; William McCarthy, MD; Stacy Schmidt, PhD; Laurie Traetow, CAE


Topic Video
Open to view video.
Open to view video.
Fat Restriction or Carbohydrate Restriction for the Treatment of Diabetes - Part 4: Panel Discussion
Open to listen to or download MP3 audio.
Open to listen to or download MP3 audio.
OMA Ondemand Survey
5 Questions